Table 2.

Posttransplant graft survival according to the pretransplant variables

	Univariate analysis				Multivariate analysis
	1‐YSR (%)	3‐YSR (%)	5‐YSR (%)	p	HR	95% CI	p
Age
≤59 years	82.9	77.7	76.4	0.005	1.92	0.97–3.79	0.060
≥60 years	70.6	52.9	47.1
Sex
Male	84.6	79.2	77.6	0.005	1.84	1.19–2.84	0.006
Female	75.3	66.7	65.4
Etiology
HBV	83.5	77.7	76.2	0.251
Non‐HBV	76.1	70.0	70.0
HCC
None	82.9	78.1	76.7	0.018	1.795	1.04–3.11	0.037
Yes	77.1	62.3	59.3
ACLF
None	89.8	82.5	81.0	0.035	1.61	1.03–2.50	0.035
Yes	76.8	72.1	70.5
Graft
RL	83.7	76.4	75.5	0.324
LL	75.8	72.7	66.7
Dual	82.0	77.0	77.0
GRWR (%)
<0.8	81.8	66.7	63.6	0.010	1.06	0.77–1.47	0.729
0.8–0.99	89.5	85.1	84.2
≥1.0	78.3	72.2	71.1
HRS
None	85.3	80.2	79.2	0.042	0.80	0.41–1.58	0.523
Yes	77.7	69.9	68.4
HD
None	84.6	78.0	76.4	0.204
Yes	75.3	70.3	70.3
HEP
Grade 0, 1, 2	85.4	77.6	76.3	0.457
Grade 3, 4	75.9	74.1	72.2
Ventilator
None	84.2	76.8	75.6	0.405
Yes	75.0	73.5	72.1
ICU stay
None	87.3	80.7	79.2	0.017	0.76	0.42–1.39	0.376
Yes	74.6	70.0	68.4
Vasopressor
None	84.5	78.3	76.5	0.021	1.95	1.12–3.40	0.19
Yes	64.9	62.2	62.2

Univariate analysis using the Kaplan–Meier method with log rank test, multivariate analysis using Cox proportional hazards regression method with a stepwise procedure. 1‐,3‐,5‐YSR, 1, 3, and 5‐year graft survival rate; HR, hazard ratio; CI, confidence interval; p, p‐value; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; ACLF, acute‐on‐chronic liver failure; RL, right hemiliver; LL, left hemiliver; Dual, dual‐graft with two left livers or right and left liver; GRWR, graft‐to‐recipient weight ratio; HRS, hepatorenal syndrome; HD, hemodialysis; HEP, hepatic encephalopathy; ICU, intensive care unit.